Seattle biotech company doubles space with new lease in Interbay
Curi Bio, a Seattle-based biotech company, has significantly expanded its operations with a new 13,942-square-foot lease in the Interbay neighborhood of Seattle.
Eric Swanson, vice president of operations, remarked, “We wanted some more room to expand. It gives us room to grow our operations and grow some of our research efforts and grow our team a little bit over the years.”
Founded in 2015, Curi Bio makes stem cell-based tissue models and data analysis tools for drug discovery. The company’s eventual goal is to double headcount, including adding to its commercial team, with a mix of employees in Seattle and other regions in the U.S.